Full Chemo Doses May Improve Survival in Breast Cancer
Maintaining full doses of chemo especially important early in the treatment course.
Home
Nelfinavir Plus Lenalidomide, Dexamethasone Improves Response in Lenalidomide-Refractory Multiple Myeloma
Results of a phase 1/2 trial demonstrated the efficacy of nelfinavir in combination with lenalidomide and dexamethasone for lenalidomide-refractory MM.
The Case for Immunotherapy Trials That Reflect the Real World of Metastatic Melanoma
The problem of low representation of racial minorities is especially urgent during the era of immunotherapy trials.
Real-World Insight on Patients With Multiple Myeloma: Results Drawn From a Large Health Plan
A retrospective cohort study identified real-world epidemiology, treatment patterns, and survival outcomes in patients with multiple myeloma in Israel.
Ribociclib Shown to Penetrate the Blood-Brain Barrier in Glioblastoma
A phase 0 study of ribociclib in patients with recurrent glioblastoma seeks to inform the feasibility of the use of CDK 4/6 inhibitors for deadly brain tumors.
Intrauterine Device Use May Reduce Incidence of Ovarian Cancer
Novel noncontraceptive benefit seen for all intrauterine devices.
A Decade of Treatments Administered to Elderly Patients With Hodgkin Lymphoma at a Single Center: New Insights
A single-center retrospective cohort analysis revealed real-world insights into possible treatments for elderly patients with Hodgkin lymphoma.
Malnutrition Common in Older Brazilians Hospitalized for Cancer
Most prevalent nutrition impact symptoms include no appetite, dry mouth.
Use of Interim PET/CT to Stratify Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
Patients with positive interim PET/CT demonstrated poorer overall and progression-free survival compared with patients with negative interim PET/CT.
Venetoclax Plus Hypomethylating Agents May Offer Treatment Backbone for High-Risk AML
Over half of patients with TP53-mutated acute myeloid leukemia who received the combination therapy experienced a response.
Want to read more?
Please login or register first to view this content.
Next post in Hematologic Cancers News
